サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1654636

毛孔性角化症治療の世界市場（2025年～2033年）

Global Keratosis Pilaris Treatment Market - 2025-2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
毛孔性角化症治療の世界市場（2025年～2033年）
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の毛孔性角化症治療の市場規模は、2024年に73億米ドルに達し、2033年には133億4,000万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは6.1％で成長する見込みです。

毛孔性角化症（KP）は、毛包に蓄積したケラチンによって引き起こされる、小さく盛り上がった隆起を特徴とする一般的な良性の皮膚疾患です。主に腕、大腿、顔面に発症します。美容上の懸念につながることもあり、治療が求められます。毛孔性角化症治療市場は、認知度の高まりと有病率の増加により拡大しています。治療の選択肢は、AHAやレチノイドのような局所的な剥離剤からレーザー治療のような専門的な介入まで幅広く、家庭用機器や天然製品への関心が高まっています。

市場力学：

促進要因と抑制要因

毛孔性角化症の有病率の増加

毛孔性角化症の有病率の増加が毛孔性角化症治療市場を牽引するとみられます。毛孔性角化症が広く認知されるようになるにつれ、美容上の懸念に対処する効果的なソリューションに対する需要が高まっています。このような罹患率の増加は、市販のクリームから高度な皮膚科学的処置まで、さまざまな治療オプションの利用可能性を拡大すると予想されます。これは人々の間でよく見られる症状です。例えば、2023年の国立衛生研究所によると、毛孔性角化症は一般的な皮膚科疾患であるとされています。最も一般的な患者層は青少年で、50～80％が罹患しています。この疾患は成人にもよく見られ、成人人口の40％が罹患しています。

毛孔性皮膚炎を管理したり目立たなくしたりする方法を求める人が増えていることが、市場の成長をさらに押し上げ、より多くの消費者層を生み出し、専門家による治療と家庭での治療の両方の需要を促進しています。

治療に伴う副作用

外用レチノイドやレーザー治療による皮膚の炎症、発赤、剥離など、特定の毛孔性角化症治療に伴う副作用は、治療の継続を制限し、市場の妨げになると予想されます。不快感や副作用の可能性は、特に敏感肌の患者のコンプライアンス低下につながる可能性があります。このような特定の治療法に対する消極的な姿勢は、永久的な治癒というよりも継続的な管理の必要性と相まって、より積極的な治療法や専門的な治療法の採用を遅らせ、毛孔性角化症治療市場全体の成長を制限する可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 毛孔性角化症の罹患率の増加
    • 抑制要因
      • 治療に伴う副作用
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 タイプ別

  • 市販
  • 処方箋

第7章 治療タイプ別

  • 局所角質除去剤
    • ローション
    • クリーム
    • その他
  • 局所用レチノイド
    • トレチノイン
    • タザロテネ
    • その他
  • レーザー治療
  • その他

第8章 流通チャネル別

  • 院内薬局
  • オンライン薬局
  • 小売薬局

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • NEOSTRATA SA
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 実績および予測の製品販売
      • 製品販売量
    • 財務概要
      • 企業収益
      • 地域別収益シェア
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • SLMD Skincare
  • Advantice Health, LLC.
  • BEIERSDORF
  • Touch Skin Care
  • G J PHARMACEUTICALS LLP
  • E-derma Pharma India Pvt. Ltd.
  • VI Aesthetics
  • Bambang Pharmaceutical Depot Inc.
  • MooGoo

第12章 付録

目次
Product Code: PH5775

The global Keratosis Pilaris Treatment market reached US$ 7.3 billion in 2024 and is expected to reach US$ 13.34 billion by 2033, growing at a CAGR of 6.1% during the forecast period 2025-2033.

Keratosis pilaris (KP) is a common, benign skin condition characterized by small, raised bumps caused by keratin buildup in hair follicles. It primarily affects the arms, thighs, and face. It can lead to cosmetic concerns, prompting treatment demand. The keratosis pilaris treatment market is expanding due to growing awareness and the increasing prevalence of the condition. Treatment options range from topical exfoliants like AHAs and retinoids to professional interventions such as laser therapies, with a rising interest in at-home devices and natural products.

Market Dynamics: Drivers & Restraints

Increasing prevalence of keratosis pilaris

The increasing prevalence of keratosis pilaris is expected to drive the keratosis pilaris treatment market. As keratosis pilaris becomes more widely recognized, there is a growing demand for effective solutions to address its cosmetic concerns. This higher incidence rate is expected to expand the availability of various treatment options, from over-the-counter creams to advanced dermatological procedures. It is a common condition occurring among the individuals. For instance, according to the National Institute of Health in 2023, it is stated that keratosis pilaris is a common dermatologic condition. The most common patient population is adolescents, with 50 to 80 percent affected. The disorder is also frequently seen in adults, with 40 percent of the adult population affected.

The rising number of people seeking ways to manage or reduce the appearance of KP further boosts market growth, creating a larger consumer base and fueling demand for both professional and at-home treatments.

Side effects associated with the treatment

Side effects associated with certain keratosis pilaris treatments, such as skin irritation, redness, and peeling from topical retinoids or laser therapies, are expected to hinder the market by restricting individuals from pursuing or continuing treatment. The potential for discomfort or adverse reactions may lead to decreased patient compliance, particularly for those with sensitive skin. This reluctance to use specific treatments, coupled with the need for ongoing management rather than a permanent cure, could slow the adoption of more aggressive or professional treatment options, limiting the overall growth of the keratosis pilaris treatment market.

Segment Analysis

The global keratosis pilaris treatment market is segmented based on type, treatment type, distribution channel, and region.

Treatment Type:

Topical Exfoliates is expected to dominate the global keratosis pilaris treatment market share

The topical exfoliates segment is expected to dominate the keratosis pilaris treatment market due to its accessibility, affordability, and effectiveness in managing the condition. Products containing alpha-hydroxy acids (AHAs), beta-hydroxy acids (BHAs), and urea are widely available over the counter and are often the first line of treatment for KP. These exfoliates help to remove dead skin cells and prevent keratin buildup, addressing the root cause of the condition.

As they are easy to use and offer a non-invasive solution, they appeal to a broad consumer base, driving significant demand in the market. This convenience and cost-effectiveness make topical exfoliants a preferred choice for individuals seeking to manage KP regularly.

Geographical Analysis

North America is expected to hold a significant position in the global keratosis pilaris treatment market share

North America is expected to dominate the keratosis pilaris treatment market due to a combination of factors, including a high prevalence of the condition, strong consumer awareness, and the presence of a large number of market players in the region. The region's focus on skincare and cosmetic treatments, coupled with a growing preference for non-invasive procedures, drives demand for both over-the-counter exfoliating products and professional treatments like laser therapy.

Additionally, North America has a well-established dermatology market, with easy access to specialized care and innovative treatment options, further fueling market growth. The rise of e-commerce and telemedicine also makes treatments more accessible, contributing to the region's leadership in the KP treatment market.

Competitive Landscape

The major global players in the keratosis pilaris treatment market include NEOSTRATA SA, SLMD Skincare, Advantice Health, LLC., BEIERSDORF, Touch Skin Care, G J PHARMACEUTICALS LLP, E-derma Pharma India Pvt. Ltd., VI Aesthetics, Bambang Pharmaceutical Depot Inc. and MooGoo among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Keratosis Pilaris Treatment Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Dosage
  • 3.2. Snippet by Application
  • 3.3. Snippet by Distribution Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of keratosis pilaris
    • 4.1.2. Restraints
      • 4.1.2.1. Side effects associated with the treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Over the Counter*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Prescription

7. By Treatment Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 7.1.2. Market Attractiveness Index, By Treatment Type
  • 7.2. Topical Exfoliates*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Lotions
    • 7.2.4. Creams
    • 7.2.5. Others
  • 7.3. Topical Retinoids
    • 7.3.1. Tretinoin
    • 7.3.2. Tazarotene
    • 7.3.3. Others
  • 7.4. Laser Treatment
  • 7.5. Others

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Hospitals Pharmacies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
      • 9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
      • 9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
      • 9.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.3.1. U.S.
      • 9.2.3.2. Canada
      • 9.2.3.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. NEOSTRATA SA*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. SLMD Skincare
  • 11.3. Advantice Health, LLC.
  • 11.4. BEIERSDORF
  • 11.5. Touch Skin Care
  • 11.6. G J PHARMACEUTICALS LLP
  • 11.7. E-derma Pharma India Pvt. Ltd.
  • 11.8. VI Aesthetics
  • 11.9. Bambang Pharmaceutical Depot Inc.
  • 11.10. MooGoo
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us